Engineered immune cells take aim at childhood cancer
NCT ID NCT00085930
First seen Jan 07, 2026 · Last updated May 10, 2026 · Updated 20 times
Summary
This study tested a new treatment for children with high-risk neuroblastoma, a type of cancer. Researchers took the children's own immune cells (T cells) and modified them to better recognize and attack cancer cells. Some of these cells were also trained to fight a common virus to help them last longer in the body. The main goal was to check if the treatment was safe and to see how long the modified cells survived.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEUROBLASTOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Texas Children's Hospital
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.